Pain relief drug trial for mast cell syndrome stalls early
Symptom relief
Terminated
This Phase 2 trial tested whether FSD201 tablets could reduce chronic pain in adults with mast cell activation syndrome. The study planned to enroll many participants but was terminated early with only 2 people. No results are available to show if the drug works or is safe.
Phase: PHASE2 • Sponsor: Quantum Biopharma • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC